Moderna Inc (NASDAQ:MRNA): Jim Cramer Is Disappointed
We recently published a list of Jim Cramer’s Latest Portfolio: Top 9 Stocks to Buy and Sell. Since Moderna Inc (NASDAQ:MRNA) ...
FiercePharma4d
Moderna blamed after kids offered $2,000 to participate in COVID-19 vaccine trial
The PCMPA has slammed Moderna over an unapproved WhatsApp message that offered children 1,500 pounds sterling ($2,000) to ...
Pfizer v Moderna COVID vaccine patents battle to go to appeal in UK
Pfizer and Moderna's legal battle over their rival COVID-19 vaccines will continue after London's High Court on Wednesday ...
Down 13% in 1 Day, Is Moderna Stock in Trouble?
Moderna 's ( MRNA -2.63%) stock fell by 13% on Sept. 12 upon the announcement of extensive cost cuts that would affect a ...
Moderna Inc. stock rises Thursday, still underperforms market
Shares of Moderna Inc. MRNA inched 0.46% higher to $63.93 Thursday, on what proved to be an all-around positive trading ...
Moderna: Cutting Costs At Just The Worst Time
Moderna shares have dropped by over -41.67% since I last covered them over the summer. See why I continue to rate MRNA stock ...
COVID-19 2024 fall guide: Everything Canadians should know about new Moderna vaccine, current variants and more
NACI added that anyone above 6 months of age who isn't considered high risk "may receive the most recently updated vaccine in ...
Moderna Inc. stock underperforms Tuesday when compared to competitors
Shares of Moderna Inc. MRNA dropped 0.31% to $63.94 Tuesday, on what proved to be an all-around favorable trading session for ...
Seeking Alpha3d
Moderna enters green after six straight sessions in red
Moderna (NASDAQ:MRNA) shares snapped six straight sessions of losses, as the stock closed 0.46% higher at $63.93 on Thursday. The Massachusetts-based pharmaceutical company lost 8.9% in the ...
Moderna, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - MRNA
NDAQ:MRNA) Moderna, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - MRNA ...
Behind the Scenes of Moderna's Latest Options Trends
Present Market Standing of Moderna Trading volume stands at 5,013,059, with MRNA's price down by -2.52%, positioned at $68.1. RSI indicators show the stock to be may be approaching oversold. Earnings ...
As GSK discontinues HSV vaccine, opportunities remain for Moderna and BioNTech
GSK's decision not to advance the vaccine into Phase III trials ends its ambition to bring the first HSV vaccine to market.